These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [TBL] [Abstract][Full Text] [Related]
27. Death following injection sclerotherapy due to phenol toxicity. Philip AT; Marraffa JM J Forensic Sci; 2012 Sep; 57(5):1372-5. PubMed ID: 22827471 [TBL] [Abstract][Full Text] [Related]
33. Sclerotherapy of thyroid cystic nodules. Chu CH; Chuang MJ; Wang MC; Lam HC; Lu CC; Lee JK J Formos Med Assoc; 2003 Sep; 102(9):625-30. PubMed ID: 14625607 [TBL] [Abstract][Full Text] [Related]
34. The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux. Wadie GM; Tirabassi MV; Courtney RA; Moriarty KP J Laparoendosc Adv Surg Tech A; 2007 Jun; 17(3):353-9. PubMed ID: 17570788 [TBL] [Abstract][Full Text] [Related]
35. [Sclerotherapy of rectal prolapse in children]. Dekhkanov ID; Alimov RI; Abdufataev T Vestn Khir Im I I Grek; 1980 Jun; 124(6):112-4. PubMed ID: 7414844 [TBL] [Abstract][Full Text] [Related]